Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBAE Systems Regulatory News (BA.)

Share Price Information for BAE Systems (BA.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,392.00
Bid: 1,393.50
Ask: 1,394.00
Change: 19.00 (1.38%)
Spread: 0.50 (0.036%)
Open: 1,377.50
High: 1,401.00
Low: 1,374.00
Prev. Close: 1,373.00
BA. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

11 Feb 2021 08:30

RNS Number : 6909O
BAE SYSTEMS PLC
11 February 2021
 

BAE Systems announces non-executive director appointments

The Board of BAE Systems plc is pleased to announce the appointments of Dame Carolyn Fairbairn and Dr Ewan Kirk as non-executive directors, with effect from 1 March and 1 June 2021, respectively.

Dame Carolyn Fairbairn

Dame Carolyn was until the end of 2020 Director-General of the Confederation of British Industry. She brings her vast leadership experience and business acumen to the Board having held various senior leadership roles within financial services, media and government.

She was previously a non-executive director of Lloyds Banking Group, The Vitec Group plc and Capita plc. She is also a former non-executive director of the Competition and Markets Authority, the Financial Services Authority and until 2016, a Trustee of Marie Curie. Dame Carolyn also worked in government as a member of the Number 10 Policy Unit during the 1990s, following which she became a partner at McKinsey specialising in digital and media, and held senior executive roles at the BBC and ITV.

She holds a BA in Economics from Cambridge University, an MA in International Relations from the University of Pennsylvania and an MBA from INSEAD. She is an honorary fellow of Gonville and Caius College, Cambridge, and of Nuffield College, Oxford.

Dr Ewan Kirk

Dr Ewan Kirk has led multiple ventures to commercialise, apply and leverage technology and mathematics research in both business and philanthropy. He brings to the Board extensive experience in rapidly identifying and leveraging emergent scientific research, especially in data science and quantities analysis, to drive commercial results and identify new lines of business.

In 2006, he founded Cantab Capital Partners, a science-driven investment management firm, which is one of the top-performing quantitative investment companies in the UK. Ewan grew the business from a team of two with £30 million assets under management (AUM) to 60 people with over £4.5 billion AUM, before the business was acquired by GAM Investments in 2016. Prior to founding Cantab, Ewan was Partner and Head of Quantitative Strategies Group at Goldman Sachs.He is Chair of the Isaac Newton Institute for Mathematical Sciences, Chairman of DeepTech Labs, a UK-based venture capital fund that invests in deep technology businesses, and Co-Chair of the Turner Kirk Trust. He holds a PhD in General Relativity from the University of Southampton, a MASt in Mathematics from Queen's College, Cambridge and a BSc in Natural Philosophy and Astronomy from the University of Glasgow.

 

Sir Roger Carr, Chairman of BAE Systems plc, said: "I am delighted to welcome Dame Carolyn Fairbairn and Dr Ewan Kirk to the BAE Systems Board. Carolyn brings extensive business leadership and commercial experience across multiple sectors and Ewan adds a deep insight and knowledge of emergent digital technologies that have been the basis for a successful business career.

As highly respected leaders, I am confident that their wealth of experience and diverse array of complementary skills will provide further diversity of thought, whilst strengthening Board discussions, challenge and invaluable insight. I am very much looking forward to working with them both and welcome the contribution they will bring to both the skills and chemistry of the Board."

There is no further information required to be disclosed pursuant to Listing Rule 9.6.13.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASFSFUSEFSEIE
Date   Source Headline
31st May 20246:18 pmRNSTransaction in Own Shares
31st May 20243:27 pmRNSTotal Voting Rights
30th May 20245:29 pmRNSTransaction in Own Shares
29th May 20246:14 pmRNSTransaction in Own Shares
28th May 20246:01 pmRNSTransaction in Own Shares
24th May 20245:20 pmRNSTransaction in Own Shares
24th May 202412:28 pmRNSDirector/PDMR Shareholding
23rd May 20246:32 pmRNSTransaction in Own Shares
23rd May 20249:19 amRNSTransaction in Own Shares
23rd May 20249:10 amRNSTransaction in Own Shares
21st May 20246:19 pmRNSTransaction in Own Shares
20th May 20245:42 pmRNSTransaction in Own Shares
17th May 20246:28 pmRNSTransaction in Own Shares
17th May 20247:00 amRNSTransaction in Own Shares
16th May 20241:45 pmRNSDirector/PDMR Shareholding
15th May 20245:56 pmRNSTransaction in Own Shares
15th May 20241:29 pmRNSDirector Declaration
14th May 20246:29 pmRNSTransaction in Own Shares
13th May 20245:14 pmRNSTransaction in Own Shares
10th May 20246:08 pmRNSTransaction in Own Shares
9th May 20246:17 pmRNSTransaction in Own Shares
9th May 20244:52 pmRNSCompany Secretary Change
9th May 202410:49 amRNSResult of AGM
9th May 20247:00 amRNSAGM Trading Statement
8th May 20246:03 pmRNSTransaction in Own Shares
7th May 20246:17 pmRNSTransaction in Own Shares
3rd May 20245:56 pmRNSTransaction in Own Shares
2nd May 20245:41 pmRNSTransaction in Own Shares
1st May 20246:08 pmRNSTransaction in Own Shares
30th Apr 20246:12 pmRNSTransaction in Own Shares
30th Apr 202410:12 amRNSTotal Voting Rights
29th Apr 20245:18 pmRNSTransaction in Own Shares
26th Apr 20245:49 pmRNSTransaction in Own Shares
25th Apr 20246:17 pmRNSTransaction in Own Shares
24th Apr 20246:06 pmRNSTransaction in Own Shares
23rd Apr 20245:43 pmRNSTransaction in Own Shares
22nd Apr 20245:25 pmRNSTransaction in Own Shares
19th Apr 20245:23 pmRNSTransaction in Own Shares
18th Apr 20246:22 pmRNSTransaction in Own Shares
18th Apr 20244:48 pmRNSDirector/PDMR Shareholding
17th Apr 20245:38 pmRNSTransaction in Own Shares
17th Apr 20241:39 pmRNSDirector/PDMR Shareholding
16th Apr 20246:01 pmRNSTransaction in Own Shares
15th Apr 20245:26 pmRNSTransaction in Own Shares
12th Apr 20245:16 pmRNSTransaction in Own Shares
11th Apr 20246:30 pmRNSTransaction in Own Shares
11th Apr 202411:15 amRNSDoc re: AGM documents
10th Apr 20246:05 pmRNSTransaction in Own Shares
9th Apr 20246:23 pmRNSTransaction in Own Shares
8th Apr 20246:14 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.